Osteoporosis Drugs Market Expected To Grow At High Cagr During Forecast Period 2019 – 2022

 Market Scenario:

Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone tissue and subsequent higher risk of a broken fracture. It generally occurs at an advanced age and women are more susceptible to it than males by about three to four folds. WHO estimates that around 1.66 million hip fractures occur each year worldwide due to osteoporosis. According to national osteoporosis foundation about 54 million Americans suffer from osteoporosis.

The disease also has a genetic bias in that it Caucasians are more affected than Asians. The disease prevalence is lowest in African population.

The market driving factors were identified to be rise in the geriatric population, increased screening, drug induced osteoporosis, alcoholism and smoking, increased awareness and focus towards female health, rising prevalence of diseases, conditions and medical procedures that may cause bone loss such as cancer, autoimmune disorders, thalassemia, hormonal disorders, modern lifestyle etc.

The market restraints are loss of patents of block busters, greater penetration of generics and fragmentation of market, poor efficacy and side effects of present therapies, non-life threatening nature and poor symptoms of osteoporosis etc.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2479

Taking all the factors into consideration, we expect the global osteoporosis market growth which totaled ~ $10,855 million to reach 14,300 million by 2022, growing with a CAGR of 4.7%.

Study Objectives Global Osteoporosis Drugs Market:

• To provide detail analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global osteoporosis drugs market
• To provide insights about factors affecting the market growth
• To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
• To provide country level analysis of the market with respect to the current market size and future prospective
• To provide country level analysis of the market for segments by drug class (bisphosphonates, calcitonins, selective estrogen receptor modulators (SERMS), parathyroid hormone (PTH) and others), by route of administration (oral, injectable and others) and by gender (male, female and children).
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Key Players for Global Osteoporosis Drugs Market:
Some of the key players in this market are: Eli Lilly and Company, Merck & Co., Novartis International AG, Amgen Inc., F. Hoffmann La Roche Ltd., Pfizer Inc., Novo Nordisk, Teva Pharmaceutical Industries Ltd. and others.

Segments:
Global osteoporosis drugs market has been segmented on the basis of drug class which comprises bisphosphonates, calcitonin’s, selective estrogen receptor modulators (SERMS), parathyroid hormone (PTH) and others. On the basis of route of administration; market is segmented into oral, injectable and others. On the basis of gender the market is segmented into male and female.

Intended Audience:

• Osteoporosis Drugs Manufacturers
• Osteoporosis Drugs Suppliers
• Private Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Government Research Laboratories
• Contract Manufacturing Organizations

Regional Analysis of Global Osteoporosis Drugs Market:
Globally America is the largest market for osteoporosis drugs. Europe is the second-largest market for osteoporosis drugs. The developed regions are expected to hold their market leadership in the near future but with falling market share due to rise of Asia Pacific region which is expected to be fastest growing region in osteoporosis drugs market. The Asia pacific region will be led by China and India. Africa is expected to be a laggard in the global osteoporosis market.

The report for Global Osteoporosis Drugs Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/osteoporosis-drugs-market-2479

Anti-viral drugs Market 2019 - Opportunity, Driving Trends And Deep Study 2022

 Market Scenario:

The rising cases of viral disease is identified to boost the global anti-viral drugs market size. The inadequacy of dietary nutrition in people, due to increase in consumption of high calorie and low fibrous food is creating favourable condition for virus to invade human body. Hence, the need for anti-viral drugs are surging as viral infections prevail. The growing incidences of HIV and other sexually-transmitted diseases are also boosting the sales number of anti-viral drugs, hence, anticipated to prompt the anti-viral drug market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2454

The increase in cases of drug resistance is propelling extensive research and developmental undertakings for launching more effective anti-viral drugs. Additionally, the stringency in drug approval stages are taking care of the quality of drugs in the pipeline. New product launches are gaining traction for revenue generation for the anti-viral drugs market. The application of anti-viral drugs in other diseases like, bird flu, and others is also likely to prompt the global anti-viral drug market growth.

The expiry of patents for certain blockbuster anti-viral drug are stimulating generic drug competition in the anti-viral drug market. This is deepening the competitive scenario of the global anti-viral drug market over the assessment period.

However, adverse effects of anti-viral drugs and high price of anti-viral drugs can hinder the anti-viral drugs market growth over the assessment period. 

Key Players

MRFR have enlisted some of the prominent Anti-viral drugs Market Companies operating in the anti-viral drugs market. They are; Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Cipla Inc. GlaxoSmithKline Plc, Novartis International AG, Abbott Laboratories, and  Astra Zeneca AB. 

Market Segmentation:

Global anti-viral drugs market has been segmented on the basis of on the basis of application, which comprises hepatitis, HIV/AIDS, herpes, influenza and others. On the basis of mechanism of action; market is segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others.

Regional Analysis:

Depending on geographic region, anti-viral drugs market is segmented into four key regions: America, Europe, Asia Pacific, and Middle East & Africa. Globally, America is the largest market for anti-viral drugs with Europe tied for the second space. Asia Pacific region is expected to be fastest growing region in anti-viral drugs market. 

Access More Details of the Report @  https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454 

Bioinformatics Market Expected To Grow At High Cagr During Forecast Period 2022

 Bioinformatics Market Overview

According to Market Research Future (MRFR), the global bioinformatics market is projected to register CAGR of 19.8% from 2016 to 2022 (forecast period).

Bioinformatics is a combination of biology and information technology that combines biological data with information storage, distribution, and analysis techniques to support multiple areas of scientific research, including biomedicine. It uses software tools for data storage, database creation, data management, data mining, etc. The mining of these data contributes to scientific findings that are used in the study of genetics and genomes. Several bioinformatics tools are available on the market. They are categorized as functional protein & analysis tools, homology & similarity tools, sequence analysis tools, and various tools. The field encompasses a number of advanced and specialized areas of life, such as structural genomics, DNA microarrays, functional genomics, comparative genomics, medical information, and others. Such factors, therefore, help to increase the global market share of bioinformatics. 

Get a FREE Sample on Global Market @ https://www.marketresearchfuture.com/sample_request/2265

Bioinformatics Market Dynamics

The growth of bioinformatics industry is accelerated by the growing use of information technology in the healthcare sector, along with robust technological advances. The use of information technology has made it easier to store, process, access, and retrieve data. In addition, the need for innovative treatment for many diseases and successful preventive approaches continues to increase. With an increasing demand for innovation in technologies used to treat a variety of diseases, many healthcare practitioners tend to concentrate on research and development projects. In addition, the rise in R&D activities has led to an increase in the generation of data, increasing the need for effective data management technology in the healthcare sector.

However, the lack of qualified personnel, common data formats, and lack of user-friendly tools at lower prices are estimated to hinder the market growth during the forecast period. 

Bioinformatics Market Segmentation   

The global bioinformatics market has been segmented into application, services and technology, and sector. 

Based on the application, the global market for bioinformatics has been segmented into genomics, chemo-informatics, drug design, transcriptomics, molecular phylogenetics, proteomics, metabolomics, DNA sequences, and others. Genomics was the leading technology in 2013. Growing demand for pharmacogenomics in the drug development and sequence screening and implementation of technical developments aimed at handling vast sets of genomic data are key factors that account for the market share. Chemo-informatics is projected to rise steadily over the forecast period. Growing demand for biomarker discovery and production is the primary reason for projected growth over the forecast period. The transcriptomics segment is estimated to have the highest growth during the forecast period due to increased preference for companion diagnostics and personalized medicines.

Based on services and technology, the global market for bioinformatics has been segmented into data warehousing, sequence analysis, sequence manipulation, and others. 

Based on sector, the global market for bioinformatics has been segmented into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, and others. 

Bioinformatics Market Regional Analysis

The global bioinformatics market has been segmented into the Americas, Asia Pacific, Europe, and the rest of the world.

The Americas is the largest bioinformatics market in the world. Heavy investment in research and development, high adoption of new and advanced technology, well-structured regulatory outlines, and the prevalence of advanced technology are factors driving market growth in the regions.

Europe is projected to be the second-largest market over the forecast period. 

The Asian Pacific market is anticipated to be the fastest-growing market for bioinformatics. 

Bioinformatics Market Key Players                                                     

Some of the significant participants in the global bioinformatics market are Agilent Technologies, QIAGEN N. V, and Thermo Fisher Scientific Inc., Illumina, Inc., Dassault Systèmes, QIAGEN, and others.   

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/bioinformatics-market-2265 

Healthcare Personal Protection Equipment Market To Show Steady Growth, 2020

 Market Research Future (MRFR) collected data on several factors including implications of covid-19 impact on microbiome sequencing services market and demographic challenges, showed how it could move forward in the coming years.

Global Healthcare PPE Market is expected to cross USD 10.116 Billion by 2027 at a CAGR of 9.17%.  

Market Synopsis

Personal Protective Equipment (PPEs) are protective gear designed to safeguard the health of workers by minimizing the exposure to a biological agent. It is one of the necessary tools in preventing transmission of infectious diseases not only in treatment centers but also in various activities, e.g. cleaning, waste management and safe burials, and community care related to the outbreak. Components of PPE are goggles, face-shield, mask, gloves, coverall/gowns (with or without aprons), head cover, shoe cover, and others.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/9594 

Impact of Covid-19 Outbreak on Healthcare Personal Protection Equipment Market

Healthcare Personal Protection Equipment (PPE) are protective gears that are designed to safeguard the workers by minimizing the exposure to a biological agent. PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended several governments worldwide to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to countries with a high demand-supply gap.   

Several countries, including India, have considered importing PPE kits to meet its requirements from China, Singapore, and South Korea. Although a tender was rolled out last week by the government's nodal procurement agency HLL Lifecare, the government has chosen not to wait for the bids to be released, rather than source it from other countries. As of the 3rd week of April, the coronavirus (COVID-19) pandemic crossed two million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for PPE.  Furthermore, the increasing government initiatives to facilitate the import of PPE is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve the US stocks of PPE. A few of its measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions.

We have observed the massive impact of novel coronavirus on people’s lives over the last five months. It has also impacted various industries across the globe, eventually affecting the global economy. Some industries have experienced negative growth, whereas some industries have experienced tremendous demand and have generated massive revenues in this period. Covid 19 Impact on Healthcare Personal Protection Equipment market is the one of the positive impact sector on global industry

 

Healthcare Personal Protection Equipment Market Influencer

PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended the governments across the world to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to the countries with a high demand-supply gap.

Market Drivers

• As of the 3rd week of April, coronavirus (COVID-19) pandemic crossed 2 million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure the people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for Personal Protective Equipment (PPE).

• Rapid technological advancements in the field of surgery such as High-Reliability Organizing (HRO), technical advancements, and standardizing procedures are expected to have a positive impact on the hospital sector, thereby impacting the demand for personal protective equipment positively.

• Increasing government initiatives to facilitate the import of personal protective equipment is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve US stocks of personal protective equipment. The measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions.

• The emergence of local PPE manufacturers, increasing end user demand, and the rising production of cost-effective and integrated PPE is expected to boost the market growth. For instance, in India, the Union Textiles Ministry and the Health Ministry has said the government is augmenting the supplies of personal protective equipment (PPEs), including body coveralls, N-95 masks and 2-ply/3-ply surgical masks required for healthcare professionals dealing with COVID-19 cases. Furthermore, more than 130 Australian companies have responded to an urgent call to dramatically boost the manufacturing of face masks, gowns, and gloves to deal with the COVID-19 crisis.

Market Restraints

• The current global stockpile of PPE is inadequate to handle the existing and expected cases in different parts of the world, particularly for medical masks and respirators. The supply of gowns and goggles is also expected to be insufficient as the disease is spread. Surging global demand is not only driven by the increasing number of COVID-19 cases but also by misinformation, hoarding, and panic buying. The lockdown in a significant portion of the world is hampering the manufacturing of PPE.

• The high cost of raw materials (specialized clothing and other related products) is hindering the demand for PPEs in economically weak countries.

Healthcare Personal Protection Equipment Market Segmentation

By Product

• Protective Clothing: The protective clothing is further segmented into coveralls, gowns, and others. Coverall/gowns are designed to protect the torso of healthcare providers from exposure to the virus.

• Respiratory Protection: Respiratory protection is bifurcated into surgical masks, respirator masks, and others. The healthcare professionals are recommended to use surgical N95 respirators or medical respirators to protect them from the direct exposure to the COVID-19 virus.

• Head, Eye, and Face Protection: The largest segment. To prevent exposure of the eye and face from the virus, goggles or a face shield should be considered. High risk of COVID-19 and other infections through nose, eyes, and ears is among the primary reason driving the growth for this segment. The goggles must fit the contours of the user’s face and are compatible with the respirator. The use of face shields/ goggles is an integral part of standard and contact precautions for the people most at risk of COVID-19 infection.

• Protective Footwear: The use of protective footwear such as washable and disposable footwear is essential to avoid self-contamination.

• Hand protection: Hand protection is further sub-segmented into general-purpose, chemical handling, sterile gloves, and surgical. The rising awareness about hygiene and prevention from the transmission of pathogens in healthcare facilities is increasing the demand for medical gloves.

• Others

By End Use

• Hospitals & Clinics: The largest segment and expected to grow at the highest CAGR during the forecast period. The rising awareness regarding the hand protection during a viral outbreak is increasing the demand for PPEs in hospitals.

• Ambulatory Surgical Centers: The increasing number of patients visiting surgical centers is facilitating the demand for PPEs in ambulatory surgical centers.

• Academic and Research Institutes: PPEs are very effective in minimizing occupational injuries, accidents, and other hazards which otherwise result in substantial manpower and financial losses. The use of basic PPE is a must in research institutes as they protect from skin contact and contamination.

• Diagnostic Laboratories: The use of protective equipment is necessary for diagnostic laboratories to protect healthcare workers from specific hazards and hazardous materials.

• Others

By Region

• Americas: The largest regional market. The increasing government initiatives and rising concerns in terms of health and safety of healthcare professionals is boosting the demand for the same. Moreover, the rising prevalence of COVID-19 infection is majorly contributing to the growth of this region.

• Europe: The healthcare market in Northern European economies, such as Germany, U.K., and Sweden, is expected to exhibit an increase in healthcare expenditure, thereby leading to the growth in production as well as the consumption of medical devices and products.

• Asia-Pacific: The fastest-growing regional market. Emerging market players in the region, technological advancements, rising focus of government towards healthcare facilities, and high target population in the region are among the key factors driving the market growth in the region.   

• Middle East & Africa: The high penetration of personal protective equipment in developed healthcare industries of UAE, South Africa is expected to drive the growth of the market in this region.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/report/covid-19-impact-healthcare-personal-protection-equipment-market

 

 

Particle Counter Market Expected To Boost During 2019 To 2025

 Market Highlights

According to MRFR analysis, the global particle counter market is expected to register a CAGR of ~7.1% during the forecast period of 2019 to 2025 and was valued at USD 89.23 million in 2018.

A particle counter is a tool for monitoring indoor air quality to understand the concentration of particles in the air in cleanrooms and workplaces. This device would not identify specifically what kinds of dust particulates are present in the air, but it will identify how many airborne particles of a certain size are present in the environment.

The growth of the global particle counter market is determined by numerous factors such as increasing incidence of chronic disorders, stringent regulatory scenario, and the adoption of particle counters to maintain air quality. However, the high cost of particle counters and technical limitations of particle counters is projected to restrain the growth of the market during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8776 

The global particle counter market is currently dominated by several market players. The key players are involved in expansion, acquisition, and strategic collaborations to strengthen their market positions.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The market in the Americas region is anticipated to hold the largest market share owing to the high health care spending, well-developed technology, and growing geriatric population. Additionally, stringent protocol and guidelines by the FDA for the maintenance of the cleanroom environment are driving the market growth. The particle counter market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

The European particle counter market has been categorized into Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Particle counter market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the presence of a huge patient population, rapid development in technology and the expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest-growing during the forecast period. The particle counter market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The global particle counter market has been segmented based on product type, modularity, technology, and end-user.

The market, based on product type, has been divided into airborne particle counters and liquid particle counters. The airborne particle counters are likely to hold maximum market share in the global particle counter market due to the increasing use of these particle counters for cleanroom monitoring and the growing stringency of air pollution monitoring.

The global particle counter market based on technology has been segregated into online particle counters and offline particle counters. The online particle counters segment is anticipated to hold the largest share in the market due to its ability to monitoring solutions in hydraulic and lubricating systems.

The global particle counter market based on modularity has been segregated into portable particle counters, remote particle counters, and handheld particle counters. The portable particle counters segment is anticipated to hold the largest share as they are easy to carry and are designed to save time and money.

The end-user segments of the market are the medical device industry, the pharmaceutical industry, research laboratories, and others. The medical device industry segment is expected to hold the largest share of the market, due to increased R&D expenditure and the establishment of new manufacturing facilities by global pharmaceutical giants in newer geographies.

Key Players

Some of the key players in the global particle counter market are Particle Measuring Systems, Inc. (A Spectris Company), Beckman Coulter (A Danaher Corporation Company), Rion Co., Ltd., Lighthouse Worldwide Solutions, Inc., TSI Incorporated, Climate Instruments Company, Setra Systems, Met One Instruments, Inc., and Chemtrac, Inc.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/particle-counter-market-8776 

Whole Exome Sequencing Market 2019 Market Challenge, Driver, Trends & Forecast To 2025

 Market Highlights

Global Whole Exome Sequencing Market is estimated to be valued at USD 2,696.03 Million by 2025 and is expected to register a CAGR of 19.80% during the forecast period.

Whole exome sequencing is a widely used next-generation sequencing (NGS) method to determine the nucleotide sequence primarily of the protein-coding regions of an individuals related sequences, representing approximately 1% of the complete DNA sequence. The human exome represents less than 2% of the genome but contains ~85% of known disease-related variants, which makes it major usage in the identification and the determination of genetic variants causing various diseases such as Miller syndrome and Alzheimer’s.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8680

Segment Analysis

The global whole exome sequencing market has been segmented on the basis of product, technology, application, and end user. The market, based on product, has been segmented into kits, sequencer, and services. Kits are further segmented into DNA Fragmentation, End Repair, A-Tailing, And Size Selection Kits, Library Preparation, and Target Enrichment. Services are further sub-segmented into Sequencing Services, Data Analysis (Bioinformatics), and Others. The global whole exome sequencing market, by technology, has been categorized as Sequencing by Synthesis (SBS), ION Semiconductor Sequencing, and others. The market by application is segmented into diagnostics, drug discovery and development, agriculture and animal research, others. Based on end user, the market is segmented into research centers and government institutes, hospitals and diagnostics centers, pharmaceutical & biotechnology companies, and others.

Regional Analysis

The Americas was the largest market for whole exome sequencing in 2019. The growth of the Americas market is due to the high prevalence rate of cancer and other chronic disorders and rising healthcare expenditure. Additionally, favorable initiatives by the government and other organizations for the development and adoption of whole-exome sequencing technologies are driving the market for whole-exome sequencing.  For instance, in 2018, All of Us Research Program, a part of the National Institutes of Health, awarded funds over USD 28.6 million to establish three genome centers in the US. These centers aim to produce genome data for researchers and the program’s precision medicine research platform, a national resource to support studies on a variety of important health questions.

Europe is the second-largest market for whole exome sequencing with Western Europe, holding the largest market share. The European market is expected to register a sturdy growth rate during the forecast period due to rising cases of cancer and increasing programs for the adoption of genome sequencing. According to the International Agency for Research on Cancer, in 2018, there were 4,229,662 cases of cancer in Europe. This increasing number of cases of cancer and rising genome mapping programs are expected to have a positive impact on the growth of the whole exome sequencing market.

Asia-Pacific is expected to represent the highest market growth potential over the forecast period due to the growing patient pool and increasing technological advancements. The fast growth of the Asia-Pacific region is due to the increasing per capita income along with government initiatives to enhance the quality of healthcare and rising diabetes being the major concern in this region. China, India, and Australia have a lucrative market for whole exome sequencing due to the growing older population. Moreover, according to the report published by the United Nations in 2015, the number of older people aged 60 years or above in the world is predicted to grow by 56% between 2015 and 2030. 66% of the older population out of the total global population would also reside in the Asia-Pacific region.

In the Middle East & Africa, the whole exome sequencing market is driven by increasing obesity issues, rising initiatives by governments to improve patient care, and favorable reimbursement policies.

Key Players

Market Research Future (MRFR) Illumina Inc.  (US), BGI (China), Eurofins Scientific (Belgium), Thermo Fisher Scientific (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GENEWIZ (US), Ambry Genetics (US ), Macrogen, Inc. (South Korea), Integragen SA (France),  as the Key Players in the Global Whole Exome Sequencing Market.

Key Findings of the Study

• The Global Whole Exome Sequencing Market is projected to reach over USD 2,696.03 Million by 2025 at a 80% CAGR during the review period of 2019 to 2025.

• The US held a market share of 87.55% in 2019. Initiatives of major players and rising product launches are driving the market growth. For instance, In January 2020, Illumina (US) announced the launch of NextSeq 1000 and NextSeq 2000 Sequencing Systems offering breakthrough system design, chemistry innovations, and on-instrument integrated informatics for rapid secondary analysis.

• Based on product, the kits segment accounted for the largest market share of 60.9% in 2019.

• On the basis of end user, the hospitals & diagnostic laboratory segment accounted for a significant market share of 33.4% in 2018.

• Key manufacturers in the whole exome sequencing market, such as Illumina Inc., Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Inc. are adopting strategies such as geographic expansions, corporate acquisitions, and product launches as growth strategies.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/whole-exome-sequencing-market-8763 

Digital 3D Printing Market 2019 Market Challenge, Driver, Trends & Forecast To 2025

 Digital 3D Printing Market size is expected to register a CAGR of 20.54% to reach USD 5,214.8 Million by 2025. 3D Printing is a process in which physical objects are created by depositing materials in layers based on a digital model. The creation of a 3D printed object is achieved using additive processes. In an additive process, an object is created by laying down successive layers of materials until the object is created. 3D Printing enables to produce complex shapes using less material than traditional manufacturing methods. Each 3D Printing process requires software, hardware, and materials to work together.

Market Dynamics

Increasing applications of Digital 3D Printing in healthcare industry is expected to boost market growth. 3D Printing techniques have empowered medical practitioners, manufacturers of medical devices, as well as researchers due to their use in dental & orthodontic treatments, orthopedic implants, tissue engineering, and drug development. As a result, the increasing benefits of the mentioned applications would boost digital 3d printing market growth. 3D Printing technique is useful to speed up procedures and helps to minimize the trauma faced by patients due to conventional treatment options. Technological advancements in digital 3D Printing, rising public-private funding for 3D Printing activities are the major drivers that contribute to the digital 3D Printing market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8680

Segmentation

Global Digital 3D Printing Market analysis is segmented based on Component, Material, Technology, Application and End User.

The market, based on component, has been categorized as system/device and software/services. System/Device held 867.53 market value in 2018

Global digital 3D Printing market, based on material, has been segregated into polymers, metal & alloy, ceramics, and others.

Global digital 3D Printing market trends based on technology, has been segregated into stereolithography, deposition modeling, laser sintering, jetting technology, electron beam melting, and others.

Global digital 3D Printing market based on application has been categorized into dental, prosthetics, orthopedics, medical components, tissue engineering, hearing aids, drug screening, and others.

Global digital 3D Printing market, based on end user, has been segregated into hospitals & surgical centers, dental clinics & laboratories (offices), pharmaceutical & biotechnology companies, and others.

Regional Analysis

Global Digital 3D Printing Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas led the market and accounted for the largest share in 2018, owing to the existence of medical device companies and the rising prevalence of diseases along with increased adoption of treatment by patients. In North America, the US held the largest of the market share in 2018 owing to the presence of major market players, developed healthcare infrastructure, high awareness, and availability of advanced treatment options. For instance, in November 2015, a group of medical researchers from North Carolina’s Wake Forest University developed a method to print the 3D form of custom medications in the configuration of pills. As a result, increasing applications of 3D Printing is expected to drive the market growth.

Europe accounts for the second-largest share in the global digital 3D Printing market owing to the presence of favorable government initiatives & laws and target population base, rising prevalence of lifestyle-associated conditions, and the presence of developed economies such as Germany, the UK, and France. Since the ban on animal testing for cosmetics in 2013, the wellness industry had been a significant supporter of 3D Printing in Europe.

Asia-Pacific is estimated to be the fastest-growing market during the forecast period due to the increasing per capita health spending, growing older population base, rising incidence of accidents, and developing the healthcare sector in China, Japan, India, and Australia.

The Middle East & Africa digital 3D Printing market is segmented into two major regions, namely the Middle East and Africa. In this region, the Middle East is anticipated to dominate owing to the presence of countries such as Egypt, Saudi Arabia, and others. The Middle East and Africa has less economic developments and extremely low-income due to which the region accounts for the least market share but is expected to grow with the increasing cases of chronic diseases and demand for better treatments in countries.

Key Players

The Prominent Players in the Global Digital 3D Printing Market are Stratasys Ltd (US), 3D Systems, Inc. (US), Carbon, Inc. (US), EnvisionTEC (US), Formlabs (US), ExOne (US), Materialise (Europe), General Electric (US), Micron Dental (US), Renishaw PLC (UK).

Some of the key strategies followed by players operating in the Global Digital 3D Printing Market were acquisitions, expansions, product launches, partnerships, mergers, collaborations, alliances, and product approvals.

• In June 2019, Materialise received the FDA clearance for the cardiovascular planning software suite. Thus, the suite has helped clinicians to produce patient-specific 3D models for more than 20 years.

• In November 2019, ExOne introduced the X1 160PRO metal 3D printer for high-volume production of quality parts.

• In February 2019, EnvisionTEC and AvaDent digital dental solutions announced a new partnership. This partnership offered a complete digital workflow solution for digital dentures, from impressions and digital design to try-in and final restoration.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/digital-3d-printing-market-8680